Balance Sheet
Cash Flow Statement
AmortizationAmortizationAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet Income
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Amortization (2016 - 2025)

Avricore Health has reported Amortization over the past 12 years, most recently at -$318877.5 for Q4 2025.

  • Quarterly Amortization fell 422.58% to -$318877.5 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$906089.5 through Dec 2025, down 10.25% year-over-year, with the annual reading at $278819.3 for FY2025, 80.6% down from the prior year.
  • Amortization was -$318877.5 for Q4 2025 at Avricore Health, down from -$239058.6 in the prior quarter.
  • Over five years, Amortization peaked at $1.4 million in Q4 2022 and troughed at -$2.6 million in Q4 2021.
  • The 5-year median for Amortization is -$192749.6 (2022), against an average of $7439.4.
  • Year-over-year, Amortization skyrocketed 1375.66% in 2021 and then tumbled 422.58% in 2025.
  • A 5-year view of Amortization shows it stood at -$2.6 million in 2021, then skyrocketed by 155.98% to $1.4 million in 2022, then plummeted by 121.97% to -$317901.8 in 2023, then skyrocketed by 131.1% to $98852.3 in 2024, then tumbled by 422.58% to -$318877.5 in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Amortization are -$318877.5 (Q4 2025), -$239058.6 (Q3 2025), and $1.2 million (Q2 2025).